Advanced company searchLink opens in new window

CYTOLYTIX LIMITED

Company number 14306985

Filter by category

Filter by category


Confirmation statement filters

Company Results (links open in a new window)
Date (document was filed at Companies House) Type Description (of the document filed at Companies House) View / Download (PDF file, link opens in new window)
23 Sep 2024 CS01 Confirmation statement made on 18 August 2024 with no updates
16 Aug 2024 AP01 Appointment of Dr Mark Edward Eccleston as a director on 15 August 2024
16 Aug 2024 TM01 Termination of appointment of Suzanne Jane Dilly as a director on 15 August 2024
14 Jun 2024 AA Audit exemption subsidiary accounts made up to 31 December 2023
14 Jun 2024 PARENT_ACC Consolidated accounts of parent company for subsidiary company period ending 31/12/23
14 Jun 2024 AGREEMENT2 Notice of agreement to exemption from audit of accounts for period ending 31/12/23
14 Jun 2024 GUARANTEE2 Audit exemption statement of guarantee by parent company for period ending 31/12/23
19 May 2024 AD01 Registered office address changed from Eliot Park Innovation Centre 4 Barling Way Nuneaton CV10 7RH England to Stonebridge House Chelmsford Road Hatfield Heath CM22 7BD on 19 May 2024
02 Mar 2024 CH01 Director's details changed for Dr Suzanne Jane Dilly on 29 February 2024
12 Sep 2023 CS01 Confirmation statement made on 18 August 2023 with updates
28 Nov 2022 AA01 Current accounting period extended from 31 August 2023 to 31 December 2023
04 Nov 2022 SH01 Statement of capital following an allotment of shares on 23 October 2022
  • GBP 10
31 Oct 2022 AP03 Appointment of Gerry Desler as a secretary on 31 October 2022
27 Oct 2022 MA Memorandum and Articles of Association
27 Oct 2022 RESOLUTIONS Resolutions
  • RES12 ‐ Resolution of varying share rights or name
  • RES13 ‐ Creation of new class of shares 21/10/2022
  • RES10 ‐ Resolution of allotment of securities
  • RES11 ‐ Resolution of removal of pre-emption rights
  • RES01 ‐ Resolution of adoption of Articles of Association
27 Oct 2022 SH08 Change of share class name or designation
27 Oct 2022 AP01 Appointment of Professor David Edwin Thurston as a director on 21 October 2022
26 Oct 2022 PSC02 Notification of Valirx Plc as a person with significant control on 23 October 2022
26 Oct 2022 PSC07 Cessation of Charles Huang Chen as a person with significant control on 23 October 2022
26 Oct 2022 PSC07 Cessation of Martin Bernhard Ulmschneider as a person with significant control on 23 October 2022
26 Oct 2022 AP01 Appointment of Dr Suzanne Jane Dilly as a director on 21 October 2022
26 Oct 2022 AP01 Appointment of Mr Mark Treharne as a director on 21 October 2022
22 Aug 2022 PSC01 Notification of Charles Huang Chen as a person with significant control on 19 August 2022
22 Aug 2022 PSC07 Cessation of Charles Huang Chen as a person with significant control on 19 August 2022
19 Aug 2022 NEWINC Incorporation
Statement of capital on 2022-08-19
  • GBP 2